resveratrol trans low dose
Selected indexed studies
- Low-Dose Trans-Resveratrol Ameliorates Diabetes-Induced Retinal Ganglion Cell Degeneration via TyrRS/c-Jun Pathway. (Invest Ophthalmol Vis Sci, 2023) [PMID:37261387]
- Low-dose trans-resveratrol induce poly(ADP)-ribosylation-dependent increase of the PPAR-γ protein expression level in the in vitro model of non-alcoholic fatty liver disease. (Mol Biol Rep, 2020) [PMID:33006712]
- Low dose resveratrol improves cerebrovascular function in type 2 diabetes mellitus. (Nutr Metab Cardiovasc Dis, 2016) [PMID:27105868]
_Worker-drafted node — pending editorial review._
Connections
resveratrol trans low dose helps
resveratrol trans low dose protects against
Sources
- Low-Dose Trans-Resveratrol Ameliorates Diabetes-Induced Retinal Ganglion Cell Degeneration via TyrRS/c-Jun Pathway. (2023) pubmed
- Supplementation with high-dose trans-resveratrol improves ultrafiltration in peritoneal dialysis patients: a prospective, randomized, double-blind study. (2016) pubmed
- Pharmacokinetic and safety profile of trans-resveratrol in a rising multiple-dose study in healthy volunteers. (2009) pubmed
- Resveratrol-associated renal toxicity. (2004) pubmed
- Low-dose trans-resveratrol induce poly(ADP)-ribosylation-dependent increase of the PPAR-γ protein expression level in the in vitro model of non-alcoholic fatty liver disease. (2020) pubmed
- Low dose resveratrol improves cerebrovascular function in type 2 diabetes mellitus. (2016) pubmed
- Resveratrol mitigates cadmium chloride-induced cardiotoxicity in rats via AMPK-mediated signaling: The modulatory role of low-dose gamma radiation. (2025) pubmed
- The Oral Bioavailability of Trans-Resveratrol from a Grapevine-Shoot Extract in Healthy Humans is Significantly Increased by Micellar Solubilization. (2018) pubmed
- trans-resveratrol inhibits hyperglycemia-induced inflammation and connexin downregulation in retinal pigment epithelial cells. (2010) pubmed
- Beneficial effects of acute trans-resveratrol supplementation in treated hypertensive patients with endothelial dysfunction. (2018) pubmed